Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
|
|
Annovis Bio, Inc. (ANVS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/06/2023 |
8-K
| Investor presentation |
| 07/28/2021 |
8-K
| Quarterly results |
| 03/23/2021 |
8-K
| Quarterly results |
| 06/09/2020 |
8-K
| Investor presentation|
Docs:
|
"Annovis Bio to Present at the June 2020 Virtual Summer Investor Summit BERWYN, PA. – June 9, 2020 – Annovis Bio Inc. , a clinical-stage drug platform company addressing Alzheimer’ s disease , Parkinson’ s disease and other neurodegenerative diseases, today announced that CEO Maria Maccecchini, Ph.D. and CFO Jeff McGroarty, MBA, CPA, will give a virtual corporate presentation at the June 2020 Virtual Summer Investor Summit taking place online from June 9 to 12, 2020. Annovis Bio’ s presentation will be held on Wednesday, June 10, 2020 at 10:55 a.m. ET, followed by a live Q&A session. Investors can register for and access the live webcast at: https://www.webcaster4.com/Webcast/Page/2038/35035. Dr. Maccecchini and Mr. McGroarty will also be available for one-on-one meetings online. To registe...",
"Investor Presentation" |
|
|
|